{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:55:54Z","timestamp":1790873754344,"version":"4.1.0"},"reference-count":15,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Levodopa is a dopamine precursor and a mainstay treatment in the management of Parkinson\u2019s disease. Its side effects induce dyskinesia, nausea, vomiting, and orthostatic hypotension. Acute levodopa acute poisoning is uncommon, with only a few reported cases in the medical literature. Treatment of poisoning by levodopa is mainly supportive. The case of a child admitted to a hospital for acute levodopa poisoning is presented in this report.<\/jats:p>","DOI":"10.2478\/jccm-2019-0024","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T09:30:51Z","timestamp":1574933451000},"page":"157-160","source":"Crossref","is-referenced-by-count":4,"title":["Accidental Modopar<sup>\u00a9<\/sup> Poisoning in a Two-Year-Old Child: A Case Report"],"prefix":"10.2478","volume":"5","author":[{"given":"Adnane","family":"Lahlou","sequence":"first","affiliation":[{"name":"Obstetric and Pediatric Intensive Care Unit, Hassan II Academic Hospital , Fez , Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Benlamkaddem","sequence":"additional","affiliation":[{"name":"Obstetric and Pediatric Intensive Care Unit, Hassan II Academic Hospital , Fez , Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Adnane","family":"Berdai","sequence":"additional","affiliation":[{"name":"Obstetric and Pediatric Intensive Care Unit, Hassan II Academic Hospital , Fez , Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Harandou","sequence":"additional","affiliation":[{"name":"Obstetric and Pediatric Intensive Care Unit, Hassan II Academic Hospital , Fez , Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"2023122812384832133_j_jccm-2019-0024_ref_001_w2aab3b7b6b1b6b1ab1b5b1Aa","doi-asserted-by":"crossref","unstructured":"Lees A. Parkinson's disease. Practical Neurology. 2010;10(4): 240-6.","DOI":"10.1136\/jnnp.2010.217836"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_002_w2aab3b7b6b1b6b1ab1b5b2Aa","doi-asserted-by":"crossref","unstructured":"Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017;124(8):901-5.","DOI":"10.1007\/s00702-017-1686-y"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_003_w2aab3b7b6b1b6b1ab1b5b3Aa","doi-asserted-by":"crossref","unstructured":"Hoglinger GU, Kassubek J, Csoti I, et al Differentiation of atypical Parkinson syndromes. J Neural Transm (Vienna). 2017;124(8):997-1004.","DOI":"10.1007\/s00702-017-1700-4"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_004_w2aab3b7b6b1b6b1ab1b5b4Aa","doi-asserted-by":"crossref","unstructured":"Hayes MT. Parkinson's Disease and Parkinsonism. Am J Med. 2019;132(7):802-7.","DOI":"10.1016\/j.amjmed.2019.03.001"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_005_w2aab3b7b6b1b6b1ab1b5b5Aa","doi-asserted-by":"crossref","unstructured":"Cedarbaum JM. Clinical Pharmacokinetics of Anti-Parkinsonian Drugs. Clin Pharmacokinet. 1987;13(3):141-78.","DOI":"10.2165\/00003088-198713030-00002"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_006_w2aab3b7b6b1b6b1ab1b5b6Aa","unstructured":"Katzung B, Masters S, Trevor A. Basic & clinical pharmacology, (2012), New York: McGraw-Hill Medical; 2012. p. 75-83."},{"key":"2023122812384832133_j_jccm-2019-0024_ref_007_w2aab3b7b6b1b6b1ab1b5b7Aa","unstructured":"Marsden CD. Problems with long-term levodopa therapy for Parkinson's disease. Clin Neuropharmacol. 1994;17(Suppl 2):S32-44."},{"key":"2023122812384832133_j_jccm-2019-0024_ref_008_w2aab3b7b6b1b6b1ab1b5b8Aa","doi-asserted-by":"crossref","unstructured":"Hoehn MM, Rutledge CO. Acute overdose with levodopa. Clinical and biochemical consequences. Neurology 1975;25(8):792-4.","DOI":"10.1212\/WNL.25.8.792"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_009_w2aab3b7b6b1b6b1ab1b5b9Aa","doi-asserted-by":"crossref","unstructured":"Sporer KA. Carbidopa-levodopa overdose. Am J Emerg Med. 1991;9(1)47-8.","DOI":"10.1016\/0735-6757(91)90014-B"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_010_w2aab3b7b6b1b6b1ab1b5c10Aa","doi-asserted-by":"crossref","unstructured":"Walsh SJ, Katz KD. Antiparkinsonian Agents. In Brent J et al Eds: Critical Care Toxicology, Springer International Publishing. 2016. pp. 1-21.","DOI":"10.1007\/978-3-319-20790-2_12-1"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_011_w2aab3b7b6b1b6b1ab1b5c11Aa","doi-asserted-by":"crossref","unstructured":"Delmas G, Rothmann C, Flesch F. Acute overdose with controlled-release levodopa-carbidopa. Clin Toxicol (Phila). 2008;46(3):274-7.","DOI":"10.1080\/15563650701352170"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_012_w2aab3b7b6b1b6b1ab1b5c12Aa","unstructured":"Zanelli M, Zaneti E, Bisagni A, et al Severe acute colitis related to levodopa treatment. Pathologica. 2018;110(1):75-7."},{"key":"2023122812384832133_j_jccm-2019-0024_ref_013_w2aab3b7b6b1b6b1ab1b5c13Aa","doi-asserted-by":"crossref","unstructured":"Vermund SH, Goldstein RG, Romano AA, Atwood SJ. Accidental bromocriptine ingestion in childhood. J Pediatr, 1984;105(5):838-40.","DOI":"10.1016\/S0022-3476(84)80319-4"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_014_w2aab3b7b6b1b6b1ab1b5c14Aa","doi-asserted-by":"crossref","unstructured":"Fox SH, Brotchie JM. Viewpoint: Developing drugs for levodopa-induced dyskinesia in PD: Lessons learnt, what does the future hold? Eur J Neurosci. 2019;49(3):399-409.","DOI":"10.1111\/ejn.14173"},{"key":"2023122812384832133_j_jccm-2019-0024_ref_015_w2aab3b7b6b1b6b1ab1b5c15Aa","doi-asserted-by":"crossref","unstructured":"Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016;76(7):759-77.","DOI":"10.1007\/s40265-016-0566-3"}],"container-title":["The Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/jccm\/5\/4\/article-p157.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciendo.com\/pdf\/10.2478\/jccm-2019-0024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T12:39:02Z","timestamp":1703767142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.2478\/jccm-2019-0024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,11,27]]},"published-print":{"date-parts":[[2019,11,27]]}},"alternative-id":["10.2478\/jccm-2019-0024"],"URL":"https:\/\/doi.org\/10.2478\/jccm-2019-0024","relation":{},"ISSN":["2393-1817"],"issn-type":[{"value":"2393-1817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}